SynthesisMedicina (Kaunas, Lithuania)2023

Efficacy and Safety of Apixaban versus Dalteparin as a Treatment for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis.

Miguel A Arce-Huamani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.